GW Pharmaceuticals Plc (GWPH)

168.83
7.17 4.07
NASDAQ : Health Technology
Prev Close 176.00
Open 175.90
Day Low/High 167.23 / 176.49
52 Wk Low/High 90.14 / 179.65
Volume 538.40K
Avg Volume 511.10K
Exchange NASDAQ
Shares Outstanding 30.45M
Market Cap 5.36B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

Party leaders will have to work toward merging the two versions of tax reform into one final bill.

Hold on for a Wild Ride: Cramer's 'Mad Money' Recap (Friday 12/1/17)

Hold on for a Wild Ride: Cramer's 'Mad Money' Recap (Friday 12/1/17)

From tax cuts to the Flynn fallout, Jim Cramer says investors have to be covered.

Enjoy the Holiday Trading While It Lasts

Enjoy the Holiday Trading While It Lasts

Market momentum goes on a rampage.

GW Pharmaceuticals And U.S. Subsidiary Greenwich Biosciences To Present Epidiolex® (cannabidiol) Data And Educational Programs At The American Epilepsy Society Annual Meeting

GW Pharmaceuticals And U.S. Subsidiary Greenwich Biosciences To Present Epidiolex® (cannabidiol) Data And Educational Programs At The American Epilepsy Society Annual Meeting

Over 20 abstracts released online today from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet syndrome and from Expanded Access Program

Energy Sector Stirs a Lot of Heat

A continued rise isn't the best thing.

Zogenix Soars After Epilepsy Drug Meets Primary Endpoint -Biotech Movers

Zogenix Soars After Epilepsy Drug Meets Primary Endpoint -Biotech Movers

The Emeryville, Calif.-based firm said its first Phase 3 study of ZX008 in Dravet syndrome achieved its primary endpoint. Dravet syndrome is a form of epilepsy.

Snap, Kinder Morgan, Iconix Brands: 'Mad Money' Lightning Round

Snap, Kinder Morgan, Iconix Brands: 'Mad Money' Lightning Round

Jim Cramer is bearish on Iconix Brands, Kinder Morgan, Snap and GW Pharmaceuticals.

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap (Wed 8/30/17)

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap (Wed 8/30/17)

From political signals to the rebuilding and recovery efforts in Texas, Jim Cramer says investors should pay attention to what's supporting stocks.

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Evercore ISI analyst Josh Schimmer is bullish on biotech.

Snap-On, Teekay Shipping, FLIR Systems, GW Pharmaceuticals: 'Mad Money' Lightning Round

Snap-On, Teekay Shipping, FLIR Systems, GW Pharmaceuticals: 'Mad Money' Lightning Round

Jim Cramer is bearish on Snap-On, Teekay Shipping, FLIR Systems, and GW Pharmaceuticals.

Time to Raise Some Cash: Cramer's 'Mad Money' Recap (Tuesday 8/1/17)

Time to Raise Some Cash: Cramer's 'Mad Money' Recap (Tuesday 8/1/17)

Jim Cramer says last week's selloff played out just like he predicted, and you haven't missed the sale.

10 Stocks to Give as Gifts

10 Stocks to Give as Gifts

Stocks can be a good gifts for individuals since they can be instrumental in wealth creation and demonstrate the power of compounding.

The Activist Who Pushed Whole Foods Into the Arms of Amazon Could Target These Companies Next

The Activist Who Pushed Whole Foods Into the Arms of Amazon Could Target These Companies Next

Here are the activist investor's next potential targets.

Launch of Cannabis ETF May Not Be Best Option for Investors

Launch of Cannabis ETF May Not Be Best Option for Investors

Although a cannabis ETF launched in April, investors are still likely to find more value in buying individual stocks in the sector, according to traders.

Alibaba, LAM Research, Yahoo, Applied Materials, Momo: 'Mad Money' Lightning Round

Alibaba, LAM Research, Yahoo, Applied Materials, Momo: 'Mad Money' Lightning Round

Jim Cramer takes on LAM Research, Yahoo, Alibaba, Applied Materials, and Momo in the Lightning Round.

More Companies Making New Highs: Cramer's 'Mad Money' Recap (Wednesday 5/31/17)

More Companies Making New Highs: Cramer's 'Mad Money' Recap (Wednesday 5/31/17)

This is not just a tech-led rally, says Jim Cramer. Keep an eye on stocks like Boeing, CSX, 3M and Carnival.

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

Aerie Pharmaceuticals, BioCryst Pharmaceuticals and GW Pharmaceuticals were among the biotech movers in premarket trading on Thursday.

Analysts' Actions -- Chemours, Incyte, Visteon, Toyota and More

Analysts' Actions -- Chemours, Incyte, Visteon, Toyota and More

Here are Friday's top research calls, including upgrades for Chemours, Incyte and Toyota, and new coverage of Visteon.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: SOHO, TM, VEC, WWW Downgrades: BID, FF, GWPH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Bull Market Reaching Mature Stage, Dow Could Dip to 19,000

Bull Market Reaching Mature Stage, Dow Could Dip to 19,000

The rallies in the stock market could be indicators of irrational exuberance and are not sustainable because of anemic growth, low unemployment and high valuations in equities.